From: STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Inhibitors | Mechanisms of action | In vitro activity | In vivo activity | Reference |
---|---|---|---|---|
Strategy 1: Target upstream regulators of STAT3 | ||||
 Carfilzomib | Inhibits IL-6/STAT3 signaling pathway | Inhibits mitosis and proliferation and induces apoptosis | Reduces serum IL-6 levels in tumor-bearing mice | [87] |
 Manuka honey | Inhibits IL-6/STAT3 signaling pathway | Inhibits cell viability and colony formation, induces apoptosis, impairs cell migration and invasion, and inhibits angiogenesis | NR | [88] |
 Bazedoxifene | Inhibits IL6/gp130/STAT3 signaling pathway | Inhibits cell viability, colony formation and cell migration and synergistically enhances the activity of paclitaxel | Suppresses tumor growth | |
 Ganoderma lucidum extract | Inhibits IL-6/JAK/STAT3 signaling pathway | Inhibits cell viability and induces apoptosis | Suppresses tumor growth | [91] |
 Arsenic trioxide | Inhibits EZH2/NF-κB/IL-6/STAT3/VEGF signaling pathway | Inhibits angiogenesis | NR | [96] |
 Deguelin | Inhibits EGFR/STAT3 signaling pathway | Inhibits cell viability | Suppresses tumor growth | [92] |
 Picrasidine G | Inhibits EGFR/STAT3 signaling pathway | Inhibits cell viability and induces apoptosis | NR | [93] |
 Cantharidin | Inhibits EGFR/STAT3 signaling pathway | Inhibits cell viability and induces apoptosis | NR | [94] |
 Silibinin | Inhibits JAK2/STAT3/MMP2 signaling pathway | Inhibits cell viability, migration and invasion | NR | [97] |
Inhibits EGFR/STAT3/Fibronectin signaling pathway | NR | NR | [95] | |
 Ganoderic acid A | Inhibits JAK2/STAT3 signaling pathway | Inhibits cell viability and invasive capacity and induces apoptosis | NR | [98] |
 Nintedanib | Modulates SHP-1/p-STAT3 signaling pathway | Inhibits cell viability and induces apoptosis | Suppresses tumor growth | [99] |
 SC-78 | Modulates SHP-1/p-STAT3/VEGF-A signaling pathway | Inhibits cell migration and tube formation | Suppresses tumor growth and metastasis | [100] |
 1,2,3,4,6-penta-O-galloyl-beta-D-glucose | Modulates SHP-1/p-STAT3 signaling pathway | NR | Suppresses tumor growth and metastasis | [101] |
 SC-2001 | Modulates RFX-1/SHP-1/p-STAT3 signaling pathway | Inhibits cell growth and induces apoptosis | Suppresses tumor growth | |
 Isolinderalactone | Enhances SOCS3-mediated STAT3 dephosphorylation | Inhibits cell viability and colony formation and induces apoptosis | Suppresses tumor growth | [103] |
 Compound 57 | Binds to HSP90 and inhibits the expression and phosphorylation of STAT3 | Inhibits cell viability | NR | [104] |
 L80 | Binds to HSP90 and inhibits the expression and phosphorylation of STAT3 | Inhibits cell viability induces apoptosis, and suppresses BCSC-like properties | Suppresses the growth of BCSC-enriched TNBC tumors and distant metastasis | [105] |
 Nor-wogonin | Inhibits TAK1-mediated STAT3 activation | Inhibits cell viability and proliferation and induces G1 and G2/M phases arrest and apoptosis | NR | [106] |
 Thioridazine | Inhibits DRD2-mediated STAT3 activation | Inhibits cell self-renewal, proliferation, and viability and induces G1 arrest | NR | [107] |
Strategy 2: Directly bind to STAT3 and inhibit its activation | ||||
 Bt354 | Directly binds to SH2 domain of STAT3 and inhibits its phosphorylation | Inhibits cell viability, induces G2/M phase arrest and apoptosis, and impairs cell migration | Suppresses tumor growth | [108] |
 Osthole | Directly binds to STAT3 and inhibits its phosphorylation | Inhibits cell viability and induces G2/M phase arrest and apoptosis | Suppresses tumor growth | [109] |
 Arctigenin | Directly binds to SH2 domain of STAT3 and inhibits its phosphorylation and DNA binding ability | Inhibits cell viability, induces apoptosis, impairs cell migration and invasion, and sensitizes cells to chemotherapy | Suppresses tumor growth | [110] |
 Alantolactone | Directly binds to SH2 domain of STAT3 and inhibits its phosphorylation | Inhibits cell viability and colony formation and impairs cell migration and invasion | Suppresses tumor growth | [111] |
 KYZ3 | Directly binds to SH2 domain of STAT3 and inhibits its phosphorylation | Inhibits cell viability, induces apoptosis, and impairs cell migration | Suppresses tumor growth | [113] |
Strategy 3: Inhibit STAT3 phosphorylation or acetylation | ||||
 Sesquiterpene lactones fraction of Inula helenium L. | Inhibits STAT3 phosphorylation and nuclear translocation | Inhibits cell viability and induces apoptosis | Suppresses tumor growth | [114] |
 Rhus coriaria | Inhibits STAT3 phosphorylation | Inhibits angiogenesis and impairs cell migration and invasion | Suppresses tumor growth and metastasis | [115] |
 Schisandrin B | Inhibits STAT3 phosphorylation and nuclear translocation | Inhibits cell viability and colony formation, induces cell cycle arrest and apoptosis, and impairs cell migration | Suppresses tumor growth | [116] |
 Eupalinolide J | Inhibits STAT3 phosphorylation and activation | Inhibits cell viability | NR | [117] |
 Galiellalactone analogues 16 and 17 | Inhibits STAT3 phosphorylation and activation | Inhibits cell viability | NR | [118] |
 FZU-03,010 | Inhibits STAT3 phosphorylation and activation | Inhibits cell viability and induces G1 phase arrest and apoptosis | NR | [119] |
 Niclosamide | Inhibits STAT3 phosphorylation and nuclear translocation | Reverses acquired radioresistance | Sensitizes tumors to irradiation | [120] |
 Flubendazole | Inhibits STAT3 phosphorylation | Inhibits cell viability, induces G2/M phase arrest and apoptosis, and suppresses BCSC-like phenotype | Suppresses tumor growth, angiogenesis and metastasis | [121] |
 Disulfiram | Inhibits STAT3 expression and phosphorylation | Inhibits cell viability, induces apoptosis, and impairs cancer stem cell-like properties | Suppresses tumor growth and BCSC-like properties | [122] |
 Salinomycin | Inhibits STAT3 phosphorylation and activation | Inhibits cell viability, promotes anoikis, impairs cell migration and invasion, and decreases CD44+/CD24− stem-like population | NR | [123] |
 Metformin | Inhibits STAT3 phosphorylation | Inhibits cell viability | NR | [124] |
 SH-I-14 | Inhibits STAT3 acetylation and disrupts DNMT1-STAT3 interaction | Inhibits cell viability | Suppresses tumor growth | [126] |
Strategy 4: Block STAT3-DNA binding | ||||
 Methylsulfonyl-methane | Inhibits the bindings of STAT3 to VEGF promoter and STAT5 to IGF-1R promoter | Inhibits cell viability and induces apoptosis | Suppresses tumor growth | [127] |
 Isoharringtonine | Inhibits STAT3-mediated Nanog expression | Inhibits cell viability, impairs cell migration, and decreases proportion of BCSC population | NR | [128] |
 Salidroside | Inhibits the bindings of STAT3 to MMP2 promoter | Inhibits cell migration, invasion and angiogenesis | NR | [129] |